These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


337 related items for PubMed ID: 17213814

  • 1. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V, Villani MG, Cavadini E, Gariboldi M, De Cecco L, Pierotti MA, Lambert JR, Reid J, Tiberio P, Colombo N, Formelli F.
    Oncogene; 2007 Jun 07; 26(27):3952-62. PubMed ID: 17213814
    [Abstract] [Full Text] [Related]

  • 2. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
    Appierto V, Tiberio P, Villani MG, Cavadini E, Formelli F.
    Carcinogenesis; 2009 May 07; 30(5):824-31. PubMed ID: 19325135
    [Abstract] [Full Text] [Related]

  • 3. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
    Brewer M, Wharton JT, Wang J, McWatters A, Auersperg N, Gershenson D, Bast R, Zou C.
    Gynecol Oncol; 2005 Aug 07; 98(2):182-92. PubMed ID: 15907982
    [Abstract] [Full Text] [Related]

  • 4. GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells.
    Jiang T, Soprano DR, Soprano KJ.
    J Cell Physiol; 2007 Sep 07; 212(3):771-9. PubMed ID: 17474084
    [Abstract] [Full Text] [Related]

  • 5. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F.
    Cancer Res; 2006 Mar 15; 66(6):3238-47. PubMed ID: 16540676
    [Abstract] [Full Text] [Related]

  • 6. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.
    Appierto V, Villani MG, Cavadini E, Lotan R, Vinson C, Formelli F.
    Cell Death Differ; 2004 Mar 15; 11(3):270-9. PubMed ID: 14647238
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH, Wan Z, Kang YH, Sposto R, Reynolds CP.
    J Natl Cancer Inst; 2008 Apr 16; 100(8):580-95. PubMed ID: 18398104
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 16; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

  • 9. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
    Lovat PE, Oliverio S, Ranalli M, Corazzari M, Rodolfo C, Bernassola F, Aughton K, Maccarrone M, Hewson QD, Pearson AD, Melino G, Piacentini M, Redfern CP.
    Cancer Res; 2002 Sep 15; 62(18):5158-67. PubMed ID: 12234979
    [Abstract] [Full Text] [Related]

  • 10. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM, Penland SN, Padilla GM, Selvan RS, Kim CS, Fine RL, Robertson CN.
    Cell Growth Differ; 1997 Jan 15; 8(1):101-11. PubMed ID: 8993839
    [Abstract] [Full Text] [Related]

  • 11. Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.
    Appierto V, Cavadini E, Pergolizzi R, Cleris L, Lotan R, Canevari S, Formelli F.
    Br J Cancer; 2001 Jun 01; 84(11):1528-34. PubMed ID: 11384104
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.
    Zuco V, Zanchi C, Cassinelli G, Lanzi C, Supino R, Pisano C, Zanier R, Giordano V, Garattini E, Zunino F.
    Cell Death Differ; 2004 Mar 01; 11(3):280-9. PubMed ID: 14657960
    [Abstract] [Full Text] [Related]

  • 13. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines.
    Holmes WF, Soprano DR, Soprano KJ.
    J Cell Physiol; 2004 Jun 01; 199(3):317-29. PubMed ID: 15095280
    [Abstract] [Full Text] [Related]

  • 14. AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.
    Tiberio P, Cavadini E, Callari M, Daidone MG, Appierto V.
    PLoS One; 2012 Jun 01; 7(6):e39968. PubMed ID: 22761939
    [Abstract] [Full Text] [Related]

  • 15. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H, Cheepala S, McCauley E, Coombes K, Xiao L, Fischer SM, Clifford JL.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [Abstract] [Full Text] [Related]

  • 16. Retinoids and ovarian cancer.
    Zhang D, Holmes WF, Wu S, Soprano DR, Soprano KJ.
    J Cell Physiol; 2000 Oct 01; 185(1):1-20. PubMed ID: 10942515
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.
    Holmes WF, Soprano DR, Soprano KJ.
    J Cell Biochem; 2003 May 15; 89(2):262-78. PubMed ID: 12704790
    [Abstract] [Full Text] [Related]

  • 18. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
    Colombo N, Formelli F, Cantù MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, Decensi A.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 15; 15(10):1914-9. PubMed ID: 17035399
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
    Runnebaum IB, Brüning A.
    Clin Cancer Res; 2005 Sep 01; 11(17):6325-32. PubMed ID: 16144937
    [Abstract] [Full Text] [Related]

  • 20. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
    Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, Escalon E, Melnick SJ.
    Anticancer Res; 2005 Sep 01; 25(5):3293-302. PubMed ID: 16101141
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.